Overcoming time pressure and the global shortage of test kits and reagents, the 8-member Microbiology team from Gleneagles Hospital Hong Kong’s Clinical Laboratory has made in-house COVID-19 testing a reality, about two months after Hong Kong confirmed its first COVID-19 case.
Today, Gleneagles Hospital Hong Kong is capable of testing up to 150 COVID-19 samples daily in its laboratory. It uses two test platforms (POCT or point of care testing and PCR or polymerase chain reaction testing), to provide quality and efficient service to meet our patients’ needs.
Between end of March and end of May, the hospital tested more than 200 cases, while supporting the Hong Kong Government Department of Health’s Community Deep Throat Saliva Surveillance Programme with about 300 cases.
The team is ramping up the laboratory’s testing capacity to meet the anticipated surge in testing demand as the government prepares to open up its borders to businesses travellers with negative COVID-19 nucleic acid testing result certification.
By making COVID-19 testing available to our patients and the medical needs of our clinicians, Gleneagles Hospital Hong Kong is helping to stem the spread of the virus in the community. It is also keeping our hospital safe for our inpatients and frontline staff, ensuring that it continues to provide uninterrupted healthcare services during the COVID-19 pandemic.
Related Stories
Gleneagles Hong Kong and CTF Life Partner to Deliver Seamless, Personalised Healthcare Experiences
IHH Singapore Honours Its Healthcare Humanity Award Recipients 2025
Mount Elizabeth Royal Square: Specialised Day Care, All in a Day
Parkway Radiology Launches MammoXpress to Bring Preventive Care Closer to Women
Mount Elizabeth Hospital Walks the Talk for Health and Community
Championing Mental Health: Care That Empowers, Where It Matters
"Care That Empowers, Where It Matters" is at the heart of IHH Healthcare's Mental Health Week from 11 to 17 October 2025 to foster a supportive workplace.
